PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

ivermectin Side Effects

The reactions most often reported to the FDA for ivermectin (also sold as Stromectol), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

5,936
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of ivermectin come from 5,936 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 5,936 reports to the FDA Adverse Event Reporting System (FAERS) for ivermectin (Stromectol): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

5,936

Reports Mentioning Death

540

9.1% of reports — not proof the medicine caused the death

Hospitalizations

2,144

36.1% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

HEADACHE
634
ASTHENIA
588
PYREXIA
484
PRURITUS
374
DIARRHOEA
286
OCULAR HYPERAEMIA
255
COMA
246
CONJUNCTIVAL HAEMORRHAGE
238
ERYTHEMA
237
BACK PAIN
225
VERTIGO
217
ARTHRALGIA
203
VOMITING
197
RASH
194
FATIGUE
169
GAIT DISTURBANCE
165
NAUSEA
158

Who Reports Side Effects

Gender Distribution

Female 2,666 (52%)
Male 2,392 (47%)
Unknown 31

Age Distribution

0-17 303 (7%)
18-44 1,300 (32%)
45-64 1,362 (34%)
65-74 579 (14%)
75+ 521 (13%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 540 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 99
STRONGYLOIDIASIS 61
COMA 55
PYREXIA 50
SEPTIC SHOCK 48
ASTHENIA 45
MULTIPLE ORGAN DYSFUNCTION SYNDROME 42
SEPSIS 37
RESPIRATORY FAILURE 32
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31
PNEUMONIA 30
DIARRHOEA 24
CONDITION AGGRAVATED 23
HEADACHE 23
ACUTE KIDNEY INJURY 22
HYPOTENSION 21
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 20
CARDIAC ARREST 19

Reactions in Hospitalization Reports

Top reactions in 2,144 reports where hospitalization was an outcome.

Reaction Reports
ASTHENIA 538
HEADACHE 493
PYREXIA 426
OCULAR HYPERAEMIA 240
CONJUNCTIVAL HAEMORRHAGE 238
COMA 229
BACK PAIN 202
DIARRHOEA 202
VERTIGO 200
ARTHRALGIA 147
GAIT DISTURBANCE 144
VOMITING 143
URINARY INCONTINENCE 130
ENCEPHALOPATHY 124
PRURITUS 110
MYALGIA 105
HYPOTENSION 101
DEPRESSED LEVEL OF CONSCIOUSNESS 100

Compare ivermectin vs acyclovir →

What the FAERS Data Reveals About ivermectin Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 5,936 voluntary reports linked to ivermectin and its brand equivalents (Stromectol), spanning 2004 through 2025. Of those, 540 (9.1%) listed death as an outcome and 2,144 (36.1%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 52% were female and 47% male; age distribution skews toward 45-64, with 1,362 reports in that bracket. The single most reported reaction is headache with 634 submissions, followed by asthenia and pyrexia.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.